Similar results were obtained for the adenoma-derived cell line RG/C2 (see online supplementary figure 2C), confirming that BCL-3 acts as a potent survival factor through activation of the AKT/PKB signalling pathway in colorectal tumour cells. The gene discussed is AKT1; the disease is adenoma.